ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Humanized Bispecific Antibody Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-5Z18209
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Humanized Bispecific Antibody Market Research Report 2024
BUY CHAPTERS

Global Humanized Bispecific Antibody Market Research Report 2024

Code: QYRE-Auto-5Z18209
Report
September 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Johnson & Johnson
Astrazeneca plc
MacroGenics Inc
Allist
Genor Biopharma
Betta Pharmaceuticals
Hansoh Pharmaceutical
BIOCYTOGEN
Dizal Pharma
EpimAb Biotherapeutics
Tuowei Biotechnology
Doma Biopharmaceutical

Humanized Bispecific Antibody Market

Humanized bispecific antibodies are bispecific antibodies that have been humanized. It is a class of biological products that can bind two different antigens at the same time, and its structure and function have been optimized to make it more compatible and effective in the human body. Most Chinese companies are still in the clinical stage and fewer are listed. They are listed in the later part of the list.
The global Humanized Bispecific Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Humanized Bispecific Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Humanized Bispecific Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Humanized Bispecific Antibody include Johnson & Johnson, AstraZeneca, MacroGenics, Allist, Genor Biopharma, EpimAb Biotherapeutics, Betta Pharmaceuticals, Tuowei Biotechnology, Hansoh Pharmaceutical, Biocytogen Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Humanized Bispecific Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humanized Bispecific Antibody.
The Humanized Bispecific Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Humanized Bispecific Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humanized Bispecific Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Humanized Bispecific Antibody Market Report

Report Metric Details
Report Name Humanized Bispecific Antibody Market
Segment by Type
  • IgG-like Double Antibody
  • Fragmented Dual Antibody (FAD)
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, AstraZeneca, MacroGenics, Allist, Genor Biopharma, EpimAb Biotherapeutics, Betta Pharmaceuticals, Tuowei Biotechnology, Hansoh Pharmaceutical, Biocytogen Co., Ltd., Doma Biopharmaceutical, Dizal Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Humanized Bispecific Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Humanized Bispecific Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Humanized Bispecific Antibody Market report?

Ans: The main players in the Humanized Bispecific Antibody Market are Johnson & Johnson, AstraZeneca, MacroGenics, Allist, Genor Biopharma, EpimAb Biotherapeutics, Betta Pharmaceuticals, Tuowei Biotechnology, Hansoh Pharmaceutical, Biocytogen Co., Ltd., Doma Biopharmaceutical, Dizal Pharma

What are the Application segmentation covered in the Humanized Bispecific Antibody Market report?

Ans: The Applications covered in the Humanized Bispecific Antibody Market report are Oncology Treatment, Immune Disease Treatment, Infectious Disease Control, Others

What are the Type segmentation covered in the Humanized Bispecific Antibody Market report?

Ans: The Types covered in the Humanized Bispecific Antibody Market report are IgG-like Double Antibody, Fragmented Dual Antibody (FAD), Others

Recommended Reports

Antibody Therapeutics

Cancer Immunotherapy

Immunology & Allergies

1 Humanized Bispecific Antibody Market Overview
1.1 Product Definition
1.2 Humanized Bispecific Antibody by Type
1.2.1 Global Humanized Bispecific Antibody Market Value Comparison by Type (2024-2030)
1.2.2 IgG-like Double Antibody
1.2.3 Fragmented Dual Antibody (FAD)
1.2.4 Others
1.3 Humanized Bispecific Antibody by Application
1.3.1 Global Humanized Bispecific Antibody Market Value by Application (2024-2030)
1.3.2 Oncology Treatment
1.3.3 Immune Disease Treatment
1.3.4 Infectious Disease Control
1.3.5 Others
1.4 Global Humanized Bispecific Antibody Market Size Estimates and Forecasts
1.4.1 Global Humanized Bispecific Antibody Revenue 2019-2030
1.4.2 Global Humanized Bispecific Antibody Sales 2019-2030
1.4.3 Global Humanized Bispecific Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Humanized Bispecific Antibody Market Competition by Manufacturers
2.1 Global Humanized Bispecific Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Humanized Bispecific Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Humanized Bispecific Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Humanized Bispecific Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Humanized Bispecific Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Humanized Bispecific Antibody, Product Type & Application
2.7 Global Key Manufacturers of Humanized Bispecific Antibody, Date of Enter into This Industry
2.8 Global Humanized Bispecific Antibody Market Competitive Situation and Trends
2.8.1 Global Humanized Bispecific Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Humanized Bispecific Antibody Players Market Share by Revenue
2.8.3 Global Humanized Bispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Humanized Bispecific Antibody Market Scenario by Region
3.1 Global Humanized Bispecific Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Humanized Bispecific Antibody Sales by Region: 2019-2030
3.2.1 Global Humanized Bispecific Antibody Sales by Region: 2019-2024
3.2.2 Global Humanized Bispecific Antibody Sales by Region: 2025-2030
3.3 Global Humanized Bispecific Antibody Revenue by Region: 2019-2030
3.3.1 Global Humanized Bispecific Antibody Revenue by Region: 2019-2024
3.3.2 Global Humanized Bispecific Antibody Revenue by Region: 2025-2030
3.4 North America Humanized Bispecific Antibody Market Facts & Figures by Country
3.4.1 North America Humanized Bispecific Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Humanized Bispecific Antibody Sales by Country (2019-2030)
3.4.3 North America Humanized Bispecific Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Humanized Bispecific Antibody Market Facts & Figures by Country
3.5.1 Europe Humanized Bispecific Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Humanized Bispecific Antibody Sales by Country (2019-2030)
3.5.3 Europe Humanized Bispecific Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Humanized Bispecific Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Humanized Bispecific Antibody Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Humanized Bispecific Antibody Sales by Region (2019-2030)
3.6.3 Asia Pacific Humanized Bispecific Antibody Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Humanized Bispecific Antibody Market Facts & Figures by Country
3.7.1 Latin America Humanized Bispecific Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Humanized Bispecific Antibody Sales by Country (2019-2030)
3.7.3 Latin America Humanized Bispecific Antibody Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Humanized Bispecific Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Humanized Bispecific Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Humanized Bispecific Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Humanized Bispecific Antibody Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Humanized Bispecific Antibody Sales by Type (2019-2030)
4.1.1 Global Humanized Bispecific Antibody Sales by Type (2019-2024)
4.1.2 Global Humanized Bispecific Antibody Sales by Type (2025-2030)
4.1.3 Global Humanized Bispecific Antibody Sales Market Share by Type (2019-2030)
4.2 Global Humanized Bispecific Antibody Revenue by Type (2019-2030)
4.2.1 Global Humanized Bispecific Antibody Revenue by Type (2019-2024)
4.2.2 Global Humanized Bispecific Antibody Revenue by Type (2025-2030)
4.2.3 Global Humanized Bispecific Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Humanized Bispecific Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Humanized Bispecific Antibody Sales by Application (2019-2030)
5.1.1 Global Humanized Bispecific Antibody Sales by Application (2019-2024)
5.1.2 Global Humanized Bispecific Antibody Sales by Application (2025-2030)
5.1.3 Global Humanized Bispecific Antibody Sales Market Share by Application (2019-2030)
5.2 Global Humanized Bispecific Antibody Revenue by Application (2019-2030)
5.2.1 Global Humanized Bispecific Antibody Revenue by Application (2019-2024)
5.2.2 Global Humanized Bispecific Antibody Revenue by Application (2025-2030)
5.2.3 Global Humanized Bispecific Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Humanized Bispecific Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Humanized Bispecific Antibody Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Humanized Bispecific Antibody Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 MacroGenics
6.3.1 MacroGenics Company Information
6.3.2 MacroGenics Description and Business Overview
6.3.3 MacroGenics Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MacroGenics Humanized Bispecific Antibody Product Portfolio
6.3.5 MacroGenics Recent Developments/Updates
6.4 Allist
6.4.1 Allist Company Information
6.4.2 Allist Description and Business Overview
6.4.3 Allist Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allist Humanized Bispecific Antibody Product Portfolio
6.4.5 Allist Recent Developments/Updates
6.5 Genor Biopharma
6.5.1 Genor Biopharma Company Information
6.5.2 Genor Biopharma Description and Business Overview
6.5.3 Genor Biopharma Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Genor Biopharma Humanized Bispecific Antibody Product Portfolio
6.5.5 Genor Biopharma Recent Developments/Updates
6.6 EpimAb Biotherapeutics
6.6.1 EpimAb Biotherapeutics Company Information
6.6.2 EpimAb Biotherapeutics Description and Business Overview
6.6.3 EpimAb Biotherapeutics Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 EpimAb Biotherapeutics Humanized Bispecific Antibody Product Portfolio
6.6.5 EpimAb Biotherapeutics Recent Developments/Updates
6.7 Betta Pharmaceuticals
6.7.1 Betta Pharmaceuticals Company Information
6.7.2 Betta Pharmaceuticals Description and Business Overview
6.7.3 Betta Pharmaceuticals Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Betta Pharmaceuticals Humanized Bispecific Antibody Product Portfolio
6.7.5 Betta Pharmaceuticals Recent Developments/Updates
6.8 Tuowei Biotechnology
6.8.1 Tuowei Biotechnology Company Information
6.8.2 Tuowei Biotechnology Description and Business Overview
6.8.3 Tuowei Biotechnology Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tuowei Biotechnology Humanized Bispecific Antibody Product Portfolio
6.8.5 Tuowei Biotechnology Recent Developments/Updates
6.9 Hansoh Pharmaceutical
6.9.1 Hansoh Pharmaceutical Company Information
6.9.2 Hansoh Pharmaceutical Description and Business Overview
6.9.3 Hansoh Pharmaceutical Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hansoh Pharmaceutical Humanized Bispecific Antibody Product Portfolio
6.9.5 Hansoh Pharmaceutical Recent Developments/Updates
6.10 Biocytogen Co., Ltd.
6.10.1 Biocytogen Co., Ltd. Company Information
6.10.2 Biocytogen Co., Ltd. Description and Business Overview
6.10.3 Biocytogen Co., Ltd. Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biocytogen Co., Ltd. Humanized Bispecific Antibody Product Portfolio
6.10.5 Biocytogen Co., Ltd. Recent Developments/Updates
6.11 Doma Biopharmaceutical
6.11.1 Doma Biopharmaceutical Company Information
6.11.2 Doma Biopharmaceutical Description and Business Overview
6.11.3 Doma Biopharmaceutical Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Doma Biopharmaceutical Humanized Bispecific Antibody Product Portfolio
6.11.5 Doma Biopharmaceutical Recent Developments/Updates
6.12 Dizal Pharma
6.12.1 Dizal Pharma Company Information
6.12.2 Dizal Pharma Description and Business Overview
6.12.3 Dizal Pharma Humanized Bispecific Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dizal Pharma Humanized Bispecific Antibody Product Portfolio
6.12.5 Dizal Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Humanized Bispecific Antibody Industry Chain Analysis
7.2 Humanized Bispecific Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Humanized Bispecific Antibody Production Mode & Process
7.4 Humanized Bispecific Antibody Sales and Marketing
7.4.1 Humanized Bispecific Antibody Sales Channels
7.4.2 Humanized Bispecific Antibody Distributors
7.5 Humanized Bispecific Antibody Customers
8 Humanized Bispecific Antibody Market Dynamics
8.1 Humanized Bispecific Antibody Industry Trends
8.2 Humanized Bispecific Antibody Market Drivers
8.3 Humanized Bispecific Antibody Market Challenges
8.4 Humanized Bispecific Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Companies
Johnson & Johnson
Astrazeneca plc
MacroGenics Inc
Allist
Genor Biopharma
Betta Pharmaceuticals
Hansoh Pharmaceutical
BIOCYTOGEN
Dizal Pharma
EpimAb Biotherapeutics
Tuowei Biotechnology
Doma Biopharmaceutical
List of Tables
 Table 1. Global Humanized Bispecific Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Humanized Bispecific Antibody Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Humanized Bispecific Antibody Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Humanized Bispecific Antibody Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Humanized Bispecific Antibody Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Humanized Bispecific Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Humanized Bispecific Antibody Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Humanized Bispecific Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Humanized Bispecific Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Humanized Bispecific Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Humanized Bispecific Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Humanized Bispecific Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Humanized Bispecific Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Bispecific Antibody as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Humanized Bispecific Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Humanized Bispecific Antibody Sales by Region (2019-2024) & (K Units)
 Table 18. Global Humanized Bispecific Antibody Sales Market Share by Region (2019-2024)
 Table 19. Global Humanized Bispecific Antibody Sales by Region (2025-2030) & (K Units)
 Table 20. Global Humanized Bispecific Antibody Sales Market Share by Region (2025-2030)
 Table 21. Global Humanized Bispecific Antibody Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Humanized Bispecific Antibody Revenue Market Share by Region (2019-2024)
 Table 23. Global Humanized Bispecific Antibody Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Humanized Bispecific Antibody Revenue Market Share by Region (2025-2030)
 Table 25. North America Humanized Bispecific Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Humanized Bispecific Antibody Sales by Country (2019-2024) & (K Units)
 Table 27. North America Humanized Bispecific Antibody Sales by Country (2025-2030) & (K Units)
 Table 28. North America Humanized Bispecific Antibody Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Humanized Bispecific Antibody Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Humanized Bispecific Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Humanized Bispecific Antibody Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Humanized Bispecific Antibody Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Humanized Bispecific Antibody Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Humanized Bispecific Antibody Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Humanized Bispecific Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Humanized Bispecific Antibody Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Humanized Bispecific Antibody Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Humanized Bispecific Antibody Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Humanized Bispecific Antibody Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Humanized Bispecific Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Humanized Bispecific Antibody Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Humanized Bispecific Antibody Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Humanized Bispecific Antibody Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Humanized Bispecific Antibody Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Humanized Bispecific Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Humanized Bispecific Antibody Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Humanized Bispecific Antibody Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Humanized Bispecific Antibody Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Humanized Bispecific Antibody Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Humanized Bispecific Antibody Sales (K Units) by Type (2019-2024)
 Table 51. Global Humanized Bispecific Antibody Sales (K Units) by Type (2025-2030)
 Table 52. Global Humanized Bispecific Antibody Sales Market Share by Type (2019-2024)
 Table 53. Global Humanized Bispecific Antibody Sales Market Share by Type (2025-2030)
 Table 54. Global Humanized Bispecific Antibody Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Humanized Bispecific Antibody Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Humanized Bispecific Antibody Revenue Market Share by Type (2019-2024)
 Table 57. Global Humanized Bispecific Antibody Revenue Market Share by Type (2025-2030)
 Table 58. Global Humanized Bispecific Antibody Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Humanized Bispecific Antibody Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Humanized Bispecific Antibody Sales (K Units) by Application (2019-2024)
 Table 61. Global Humanized Bispecific Antibody Sales (K Units) by Application (2025-2030)
 Table 62. Global Humanized Bispecific Antibody Sales Market Share by Application (2019-2024)
 Table 63. Global Humanized Bispecific Antibody Sales Market Share by Application (2025-2030)
 Table 64. Global Humanized Bispecific Antibody Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Humanized Bispecific Antibody Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Humanized Bispecific Antibody Revenue Market Share by Application (2019-2024)
 Table 67. Global Humanized Bispecific Antibody Revenue Market Share by Application (2025-2030)
 Table 68. Global Humanized Bispecific Antibody Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Humanized Bispecific Antibody Price (US$/Unit) by Application (2025-2030)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Johnson & Johnson Humanized Bispecific Antibody Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. AstraZeneca Humanized Bispecific Antibody Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. MacroGenics Company Information
 Table 81. MacroGenics Description and Business Overview
 Table 82. MacroGenics Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. MacroGenics Humanized Bispecific Antibody Product
 Table 84. MacroGenics Recent Developments/Updates
 Table 85. Allist Company Information
 Table 86. Allist Description and Business Overview
 Table 87. Allist Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Allist Humanized Bispecific Antibody Product
 Table 89. Allist Recent Developments/Updates
 Table 90. Genor Biopharma Company Information
 Table 91. Genor Biopharma Description and Business Overview
 Table 92. Genor Biopharma Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Genor Biopharma Humanized Bispecific Antibody Product
 Table 94. Genor Biopharma Recent Developments/Updates
 Table 95. EpimAb Biotherapeutics Company Information
 Table 96. EpimAb Biotherapeutics Description and Business Overview
 Table 97. EpimAb Biotherapeutics Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. EpimAb Biotherapeutics Humanized Bispecific Antibody Product
 Table 99. EpimAb Biotherapeutics Recent Developments/Updates
 Table 100. Betta Pharmaceuticals Company Information
 Table 101. Betta Pharmaceuticals Description and Business Overview
 Table 102. Betta Pharmaceuticals Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Betta Pharmaceuticals Humanized Bispecific Antibody Product
 Table 104. Betta Pharmaceuticals Recent Developments/Updates
 Table 105. Tuowei Biotechnology Company Information
 Table 106. Tuowei Biotechnology Description and Business Overview
 Table 107. Tuowei Biotechnology Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Tuowei Biotechnology Humanized Bispecific Antibody Product
 Table 109. Tuowei Biotechnology Recent Developments/Updates
 Table 110. Hansoh Pharmaceutical Company Information
 Table 111. Hansoh Pharmaceutical Description and Business Overview
 Table 112. Hansoh Pharmaceutical Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Hansoh Pharmaceutical Humanized Bispecific Antibody Product
 Table 114. Hansoh Pharmaceutical Recent Developments/Updates
 Table 115. Biocytogen Co., Ltd. Company Information
 Table 116. Biocytogen Co., Ltd. Description and Business Overview
 Table 117. Biocytogen Co., Ltd. Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Biocytogen Co., Ltd. Humanized Bispecific Antibody Product
 Table 119. Biocytogen Co., Ltd. Recent Developments/Updates
 Table 120. Doma Biopharmaceutical Company Information
 Table 121. Doma Biopharmaceutical Description and Business Overview
 Table 122. Doma Biopharmaceutical Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Doma Biopharmaceutical Humanized Bispecific Antibody Product
 Table 124. Doma Biopharmaceutical Recent Developments/Updates
 Table 125. Dizal Pharma Company Information
 Table 126. Dizal Pharma Description and Business Overview
 Table 127. Dizal Pharma Humanized Bispecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Dizal Pharma Humanized Bispecific Antibody Product
 Table 129. Dizal Pharma Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Humanized Bispecific Antibody Distributors List
 Table 133. Humanized Bispecific Antibody Customers List
 Table 134. Humanized Bispecific Antibody Market Trends
 Table 135. Humanized Bispecific Antibody Market Drivers
 Table 136. Humanized Bispecific Antibody Market Challenges
 Table 137. Humanized Bispecific Antibody Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Humanized Bispecific Antibody
 Figure 2. Global Humanized Bispecific Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Humanized Bispecific Antibody Market Share by Type: 2023 & 2030
 Figure 4. IgG-like Double Antibody Product Picture
 Figure 5. Fragmented Dual Antibody (FAD) Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Humanized Bispecific Antibody Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Humanized Bispecific Antibody Market Share by Application: 2023 & 2030
 Figure 9. Oncology Treatment
 Figure 10. Immune Disease Treatment
 Figure 11. Infectious Disease Control
 Figure 12. Others
 Figure 13. Global Humanized Bispecific Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Humanized Bispecific Antibody Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Humanized Bispecific Antibody Sales (2019-2030) & (K Units)
 Figure 16. Global Humanized Bispecific Antibody Average Price (US$/Unit) & (2019-2030)
 Figure 17. Humanized Bispecific Antibody Report Years Considered
 Figure 18. Humanized Bispecific Antibody Sales Share by Manufacturers in 2023
 Figure 19. Global Humanized Bispecific Antibody Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Humanized Bispecific Antibody Players: Market Share by Revenue in Humanized Bispecific Antibody in 2023
 Figure 21. Humanized Bispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Humanized Bispecific Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Humanized Bispecific Antibody Sales Market Share by Country (2019-2030)
 Figure 24. North America Humanized Bispecific Antibody Revenue Market Share by Country (2019-2030)
 Figure 25. United States Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Humanized Bispecific Antibody Sales Market Share by Country (2019-2030)
 Figure 28. Europe Humanized Bispecific Antibody Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Humanized Bispecific Antibody Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Humanized Bispecific Antibody Revenue Market Share by Region (2019-2030)
 Figure 36. China Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Humanized Bispecific Antibody Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Humanized Bispecific Antibody Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Humanized Bispecific Antibody Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Humanized Bispecific Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Humanized Bispecific Antibody by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Humanized Bispecific Antibody by Type (2019-2030)
 Figure 55. Global Humanized Bispecific Antibody Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Humanized Bispecific Antibody by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Humanized Bispecific Antibody by Application (2019-2030)
 Figure 58. Global Humanized Bispecific Antibody Price (US$/Unit) by Application (2019-2030)
 Figure 59. Humanized Bispecific Antibody Value Chain
 Figure 60. Humanized Bispecific Antibody Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Humanized Bispecific Antibodies Market Research Report 2024
Global Bispecific Antibodies Drug Market Research Report 2025
Global Bispecific Antibody Molecular Drug Market Research Report 2025
Global Bispecific Antibody Development Platform Market Research Report 2024
Global T Cell NK Cell Engaging Bispecific Antibodies Market Research Report 2025
Global Bi Specific MAbS Market Research Report 2024
Global Fully Humanized Monoclonal Antibody Market Research Report 2024
Global Humanized Monoclonal Antibody Market Research Report 2024
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global Humanized Antibody Market Research Report 2024
Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibody Technology Platform Market Research Report 2025
Bispecific and Trispecific Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fully Humanized Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibody Therapeutic Market Insights Forecast to 2030
Global CD Targeted Bispecific Antibody Market Research Report 2024
Global Bispecific Monoclonal Antibodies Market Research Report 2024
Global Antibody Humanization Market Research Report 2025
Bispecific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bi Specific Antibodies Therapy Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions